FIDA BACHA to Child
This is a "connection" page, showing publications FIDA BACHA has written about Child.
Connection Strength
1.043
-
Prediction models of basal energy expenditure in children and adolescents across the BMI spectrum based on room calorimetry: a cross-sectional cohort study. Am J Clin Nutr. 2025 Feb; 121(2):284-292.
Score: 0.058
-
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
Score: 0.057
-
Adiposity, Insulin Resistance, Cardiorespiratory Fitness, and Bone Health in Hispanic Children. J Clin Endocrinol Metab. 2022 08 18; 107(9):e3797-e3804.
Score: 0.049
-
The relationship of sleep duration and quality to energy expenditure and physical activity in children. Pediatr Obes. 2021 06; 16(6):e12751.
Score: 0.043
-
Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
Score: 0.040
-
FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
Score: 0.040
-
Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018; 89(1):47-55.
Score: 0.035
-
Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance. J Pediatr. 2016 Nov; 178:171-177.
Score: 0.032
-
Relationship of Cardiac Structure and Function to Cardiorespiratory Fitness and Lean Body Mass in Adolescents and Young Adults with Type 2 Diabetes. J Pediatr. 2016 10; 177:159-166.e1.
Score: 0.032
-
Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes. Curr Diab Rep. 2016 07; 16(7):62.
Score: 0.032
-
Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes. Pediatr Diabetes. 2016 12; 17(8):545-558.
Score: 0.031
-
Urine Albumin-to-Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth. J Clin Endocrinol Metab. 2015 Sep; 100(9):3393-9.
Score: 0.030
-
Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood. Pediatr Diabetes. 2015 Sep; 16(6):419-26.
Score: 0.029
-
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013 Jul; 100(1):2-11.
Score: 0.026
-
Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov; 61(11):2787-95.
Score: 0.024
-
Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
Score: 0.024
-
From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
Score: 0.021
-
Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr. 2008 May; 152(5):618-21.
Score: 0.018
-
Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab. 2006 Aug; 91(8):3117-22.
Score: 0.016
-
Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017 08; 12(4):337-345.
Score: 0.016
-
Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes. 2005 Jun; 6(2):100-2.
Score: 0.015
-
Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab. 2005 May; 90(5):2725-30.
Score: 0.015
-
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
Score: 0.014
-
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Nov-Dec; 44(6):538-544.
Score: 0.014
-
Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004 Feb; 27(2):547-52.
Score: 0.014
-
Estimating circadian phase in elementary school children: leveraging advances in physiologically informed models of circadian entrainment and wearable devices. Sleep. 2022 06 13; 45(6).
Score: 0.012
-
Relationship between Arterial Stiffness and Subsequent Cardiac Structure and Function in Young Adults with Youth-Onset Type 2 Diabetes: Results from the TODAY Study. J Am Soc Echocardiogr. 2022 06; 35(6):620-628.e4.
Score: 0.012
-
Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
Score: 0.011
-
Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 07 29; 385(5):416-426.
Score: 0.011
-
?-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.
Score: 0.011
-
Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study. Pediatr Diabetes. 2020 09; 21(6):923-931.
Score: 0.011
-
?-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak. Pediatr Diabetes. 2020 02; 21(1):18-27.
Score: 0.010
-
Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 11; 42(11):2143-2150.
Score: 0.010
-
The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
Score: 0.009
-
Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
Score: 0.009
-
Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2018 12; 19(8):1379-1384.
Score: 0.009
-
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
Score: 0.009
-
Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
Score: 0.009
-
Diagnostic Evaluation, Comorbidity Screening, and Treatment of Polycystic Ovary Syndrome in Adolescents in 3 Specialty Clinics. J Pediatr Adolesc Gynecol. 2018 Aug; 31(4):367-371.
Score: 0.009
-
Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr. 2018 01; 192:86-92.e5.
Score: 0.009
-
Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off? Pediatr Diabetes. 2018 03; 19(2):205-211.
Score: 0.009
-
Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017 Jan; 40(1):85-93.
Score: 0.008
-
A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 05; 18(3):222-229.
Score: 0.008
-
Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 01; 314(21):2241-50.
Score: 0.008
-
Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatr Diabetes. 2016 12; 17(8):584-591.
Score: 0.008
-
Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
Score: 0.008
-
Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016 09; 17(6):458-65.
Score: 0.008
-
Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep; 167(3):627-32.e1-4.
Score: 0.007
-
Pre-diabetes in overweight youth and early atherogenic risk. Metabolism. 2014 Dec; 63(12):1528-35.
Score: 0.007
-
Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial. Pediatr Diabetes. 2015 Feb; 16(1):39-47.
Score: 0.007
-
25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care. 2013 Jul; 36(7):2048-53.
Score: 0.006
-
Measuring ?-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? Diabetes Care. 2013 Jun; 36(6):1607-12.
Score: 0.006
-
HbA(1c) diagnostic categories and ?-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care. 2012 Dec; 35(12):2559-63.
Score: 0.006
-
Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr. 2011; 76(6):379-85.
Score: 0.006
-
Declining ?-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care. 2011 Sep; 34(9):2033-40.
Score: 0.006
-
Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011 Jul; 96(7):2136-45.
Score: 0.006
-
One-hour plasma glucose concentration during the OGTT: what does it tell about ?-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes. 2011 Sep; 12(6):572-9.
Score: 0.006
-
?-cell autoimmunity in overweight non-diabetic youth: any implications? Pediatr Diabetes. 2011 May; 12(3 Pt 2):207-11.
Score: 0.005
-
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009 Mar; 58(3):738-44.
Score: 0.005
-
Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care. 2008 Jul; 31(7):1445-7.
Score: 0.005
-
Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008 Feb; 152(2):177-84.
Score: 0.004
-
Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007 Aug; 30(8):2091-7.
Score: 0.004
-
Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr. 2006 Dec; 149(6):809-16.
Score: 0.004
-
Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring). 2006 Sep; 14(9):1579-85.
Score: 0.004
-
Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006 Feb; 148(2):188-94.
Score: 0.004
-
Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
Score: 0.004
-
Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am. 2005 Dec; 52(6):1579-609.
Score: 0.004
-
Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005 Jan; 28(1):115-9.
Score: 0.004